GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » Net Issuance of Debt

AprilBio Co (XKRX:397030) Net Issuance of Debt : ₩0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is AprilBio Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. AprilBio Co's net issuance of debt for the three months ended in Mar. 2025 was ₩0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was ₩0 Mil.

AprilBio Co Net Issuance of Debt Historical Data

The historical data trend for AprilBio Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AprilBio Co Net Issuance of Debt Chart

AprilBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Issuance of Debt
Get a 7-Day Free Trial - - - 14,847.79 -

AprilBio Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AprilBio Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AprilBio Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of AprilBio Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

AprilBio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AprilBio Co Ltd (XKRX:397030) » Definitions » Net Issuance of Debt
Comparable Companies
XKRX:389650 XKRX:475960 XKRX:228760 XKRX:334970 XKRX:078160 XKRX:064550 XKRX:372320 XKRX:011000 XKRX:140610 XKRX:115180 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
1 Kangwon National University Road, B-602, College of Medical and Life Sciences, Kangwon National University, Gangwon Special Self-Governing Province, Chuncheon-si, KOR
Website
http://www.aprilbio.com
AprilBio Co Ltd is a bio company is developing biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual combination to serum akbumin and EX 12 helper phase antibody library technology.

AprilBio Co Headlines

No Headlines